Dr. Montes on the Relationship of MRI Imaging Characteristics With Race

Video

In Partnership With:

Jennifer Montes, MD, NYU Langone Medical Center, discusses a recent study that examined the relationship of magnetic resonance imaging (MRI) characteristics with race in breast cancer.

Jennifer Montes, MD, NYU Langone Medical Center, discusses a recent study that examined the relationship of magnetic resonance imaging (MRI) characteristics with race in breast cancer.

Patients with early-stage breast cancer in this study, Montes explains, were racially diverse, college-educated, had access to healthcare, and had a mammogram within the last year. A total of 2092 women, with a median age of 59, were examined. Most patients had invasive ductal carcinoma in situ that was ER-positive or HER2-negative, she adds.

Data showed that African-Americans had lower breast density, lower background parenchymal enhancement, and lower fibroglandular tissue compared with Caucasians. However, African-Americans had a higher body mass index (BMI). Asian-Americans had opposite results and a lower BMI, Montes says.

Notable differences were found among races with respect to tumor biology. African-Americans had higher rates of triple-negative breast cancer, though this did not translate into higher breast density on MRI.

Related Videos
Christian Marth, MD, PhD, head, professor, Department of Obstetrics and Gynecology, Innsbruck Medical University
Mansoor Raza Mirza, MD, chief oncologist, Department of Oncology, Rigshospitalet, Copenhagen University Hospital
Vijayakrishna Gadi, MD, PhD, and Megan Kruse, MD
Judy Hayek, MD, gynecologic oncology fellow, State University of New York (SUNY) Downstate College of Medicine
Leslie M. Randall, MD, MAS, professor, division head, Department of Obstetrics and Gynecology – Gynecologic Oncology, Virginia Commonwealth University School of Medicine Obstetrics and Gynecology
Dimitrios Nasioudis, MD, fellow, Gynecologic Oncology, Perelman School of Medicine, the University of Pennsylvania
Sara Corvigno, MD, PhD, translational researcher, oncology, The University of Texas MD Anderson Cancer Center
I-Chia (Daniel) Liu, MD
Robert W. Mutter, MD